[A.DI.DE.A1.S1.PSC.LE.NI.FA.D.F.ALL.EUR.I.V._X.C21.2] Primary and secondary direct investment (via dependent holding companies) / Directional principle: reporting country / Countries in America / Manufacture of basic pharmaceutical products and pharmaceutical preparations/ economic activity of the investment enterprise
Retrieved by DBnomics on May 1, 2025 (2:47 AM)
- from
- 2010=136
- to
- 2023=-152
- min:
- -377
- max:
- 566
- avg:
- 170.462
- σ:
- 283.781
Loading chart
| Period | Value | [BBK_DIFF_Y] | [BBK_OBS_STATUS] |
|---|---|---|---|
| 2010 | 136 | ||
| 2011 | 98 | -27.9 | |
| 2012 | 471 | 380.6 | |
| 2013 | -268 | -156.9 | |
| 2014 | 407 | 251.9 | |
| 2015 | -377 | -192.6 | |
| 2016 | 260 | 169.0 | |
| 2017 | NA | K | |
| 2018 | 169 | ||
| 2019 | 77 | -54.4 | |
| 2020 | 360 | 367.5 | |
| 2021 | 566 | 57.2 | |
| 2022 | 469 | -17.1 | |
| 2023 | -152 | -132.4 |
This series has no dimension.